ASCO Action Center
Immerse yourself in the latest oncological breakthroughs with the ASCO Action Center, which offers an in-depth look at the research and clinical advancements unveiled at the American Society of Clinical Oncology (ASCO) Annual Meeting and even its affiliated conferences like the Genitourinary Cancers (ASCO-GU) and Gastrointestinal Cancers Symposiums. Gain exclusive access to the expert analyses, dynamic discussions, and cutting-edge treatment strategies presented at the conference that are redefining cancer care.
1-15 of 29
Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Project Oncology®Emerging TNBC Research: Biomarkers, Genomics, and Adaptive Treatment
Roberto Leon-Ferre, MD
Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Project Oncology®Implementing Lifestyle Medicine in Breast Cancer Survivorship Care
Amy Comander, MD
Matching TNBC Treatment Intensity to Patient Needs
Project Oncology®Matching TNBC Treatment Intensity to Patient Needs
Roberto Leon-Ferre, MD
Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Project Oncology®Breast Cancer Survivorship: Why Lifestyle Medicine Matters
Amy Comander, MD
DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
Project Oncology®DPYD Testing Before Fluoropyrimidine Therapy: Benefits, Risks, and Guidance
Daniel Hertz, PhD, PharmD
Advancing HER2-Targeted Therapy in GI Cancers
Project Oncology®Advancing HER2-Targeted Therapy in GI Cancers
John H. Strickler, MD
- advertisement
How AI Is Transforming Biomarker Development in GI Oncology
Project Oncology®How AI Is Transforming Biomarker Development in GI Oncology
William Hall, MD
Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Project Oncology®Surgical Insights on Gastroesophageal Cancer: Balancing Surveillance and Intervention
Daniela Molena, MD
The Metabolic Roots of Early-Onset Colorectal Cancer
Project Oncology®The Metabolic Roots of Early-Onset Colorectal Cancer
Exercise in CRC Survivors: A Closer Look at Biomarker Effects
Project Oncology®Exercise in CRC Survivors: A Closer Look at Biomarker Effects
AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Project Oncology®AI-Assisted Colonoscopy Improves Polyp Detection and Diagnostic Accuracy
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Project Oncology®Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Aline Fares, MD
- advertisement
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Project Oncology®Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Ryan Quigley
David F. McDermott, MD
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Project Oncology®One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Investigating the Impact of Exercise on Cancer Immunotherapy Outcomes
Project Oncology®Investigating the Impact of Exercise on Cancer Immunotherapy Outcomes
Samhitha Gundakaram, MBBS
